Short answer · Medically reviewed summary · Last updated: 2026-04-08
TL;DR: Ectrodactyly, often referred to as split-hand/split-foot malformation (SHFM), is a rare congenital limb deficiency with an estimated prevalence of approximately 1 in 90,000 to 1 in 100,000 live births globally. Because it is a spectrum disorder with highly variable clinical presentation, true prevalence is likely higher than reported due to cases of mild expression that may go undiagnosed or unreported. What is the estimated prevalence and incidence of Ectrodactyly? The prevalence of Ectrodactyly is generally cited as 1 in 90,000 to 1 in 100,000 individuals, categorizing it as a rare disease.
TL;DR: Ectrodactyly, often referred to as split-hand/split-foot malformation (SHFM), is a rare congenital limb deficiency with an estimated prevalence of approximately 1 in 90,000 to 1 in 100,000 live births globally. Because it is a spectrum disorder with highly variable clinical presentation, true prevalence is likely higher than reported due to cases of mild expression that may go undiagnosed or unreported.
The prevalence of Ectrodactyly is generally cited as 1 in 90,000 to 1 in 100,000 individuals, categorizing it as a rare disease. Because Ectrodactyly is a congenital condition, the incidence at birth is synonymous with its prevalence in the population. It is important to note that these figures are estimates derived from clinical registries, such as Orphanet and the NIH GARD, and these statistics may vary based on whether the data accounts for isolated cases or those associated with complex syndromes (such as Ectrodactyly-Ectodermal Dysplasia-Clefting, or EEC syndrome).
Current clinical literature suggests that Ectrodactyly affects males and females with equal frequency. While Ectrodactyly has been observed in diverse ethnic groups worldwide, there is no strong evidence to suggest significant geographic clustering, though specific genetic mutations linked to the condition may show higher carrier frequencies in certain populations due to founder effects. Because the condition is present from birth, it is classified as a pediatric-onset condition, though individuals live with the physical manifestations of Ectrodactyly throughout their entire adult lives.
Gathering precise epidemiological data for Ectrodactyly remains a challenge for several reasons:
Ectrodactyly can be inherited in an autosomal dominant, autosomal recessive, or X-linked pattern, depending on the specific genetic mutation involved. Many cases are autosomal dominant, meaning a parent with the condition has a 50% chance of passing it to their child. However, a significant number of cases occur due to *de novo* (spontaneous) mutations, meaning there is no family history of the condition. Genetic counseling is essential for families navigating the inheritance patterns associated with Ectrodactyly.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.